Maharashtra FDA hits Patanjali Foods with notice over Karela Jamun Juice claims, recall looms

Maharashtra FDA has issued Patanjali Foods a formal notice over labelling and medicinal claims on its Karela Jamun Juice, with a mandatory recall on the table. The action targets the company's health-segment portfolio and adds fresh regulatory overhang to its packaged consumer business.

— Source publishedWed, 10 Jun, 2026, 07:49 IST·First seen Wed, 10 Jun, 2026, 07:55 IST·Source The Hindu BusinessLine

What happened

Maharashtra FDA issued a formal notice to Patanjali Foods over labelling and medicinal claims on its Karela Jamun Juice, threatening a mandatory recall of the

Key facts

  • ₹650 crore
  • ₹235.26 crore
  • ₹315 crore
  • 20 lakh homes
  • 60:40 JV

Why this matters

Reassess valuation and diligence assumptions on any Patanjali-adjacent or Ayurveda-branded targets, as label-claim liability is now a live deal-risk factor in Indian FMCG health portfolios.